These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31422386)

  • 41. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
    Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
    Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mesenchymal stem cell therapy for degenerative inflammatory disorders.
    Müller I; Lymperi S; Dazzi F
    Curr Opin Organ Transplant; 2008 Dec; 13(6):639-44. PubMed ID: 19060556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study.
    Peng Y; Ke M; Xu L; Liu L; Chen X; Xia W; Li X; Chen Z; Ma J; Liao D; Li G; Fang J; Pan G; Xiang AP
    Transplantation; 2013 Jan; 95(1):161-8. PubMed ID: 23263506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mesenchymal stem cell-based therapy in kidney transplantation.
    Chen C; Hou J
    Stem Cell Res Ther; 2016 Feb; 7():16. PubMed ID: 26852923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients.
    Bank JR; Rabelink TJ; de Fijter JW; Reinders ME
    J Immunol Res; 2015; 2015():391797. PubMed ID: 26258149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation.
    Lohan P; Murphy N; Treacy O; Lynch K; Morcos M; Chen B; Ryan AE; Griffin MD; Ritter T
    Front Immunol; 2018; 9():2666. PubMed ID: 30515159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site.
    Ben Nasr M; Vergani A; Avruch J; Liu L; Kefaloyianni E; D'Addio F; Tezza S; Corradi D; Bassi R; Valderrama-Vasquez A; Usuelli V; Kim J; Azzi J; El Essawy B; Markmann J; Abdi R; Fiorina P
    Acta Diabetol; 2015 Oct; 52(5):917-27. PubMed ID: 25808641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone marrow-derived mesenchymal stem cells inhibit acute rejection of rat liver allografts in association with regulatory T-cell expansion.
    Wang Y; Zhang A; Ye Z; Xie H; Zheng S
    Transplant Proc; 2009 Dec; 41(10):4352-6. PubMed ID: 20005397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation.
    Longoni B; Szilagyi E; Quaranta P; Paoli GT; Tripodi S; Urbani S; Mazzanti B; Rossi B; Fanci R; Demontis GC; Marzola P; Saccardi R; Cintorino M; Mosca F
    Diabetes Technol Ther; 2010 Jun; 12(6):435-46. PubMed ID: 20470228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction of N-glycolylneuraminic acid xenoantigen on human adipose tissue-derived stromal cells/mesenchymal stem cells leads to safer and more useful cell sources for various stem cell therapies.
    Komoda H; Okura H; Lee CM; Sougawa N; Iwayama T; Hashikawa T; Saga A; Yamamoto-Kakuta A; Ichinose A; Murakami S; Sawa Y; Matsuyama A
    Tissue Eng Part A; 2010 Apr; 16(4):1143-55. PubMed ID: 19863253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunosuppressive drugs for kidney transplantation.
    Halloran PF
    N Engl J Med; 2004 Dec; 351(26):2715-29. PubMed ID: 15616206
    [No Abstract]   [Full Text] [Related]  

  • 52. Mesenchymal stem cells: immune evasive, not immune privileged.
    Ankrum JA; Ong JF; Karp JM
    Nat Biotechnol; 2014 Mar; 32(3):252-60. PubMed ID: 24561556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Research Status of Mesenchymal Stem Cells in Liver Transplantation.
    You Y; Wen DG; Gong JP; Liu ZJ
    Cell Transplant; 2019 Dec; 28(12):1490-1506. PubMed ID: 31512503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Toubai T; Paczesny S; Shono Y; Tanaka J; Lowler KP; Malter CT; Kasai M; Imamura M
    Curr Stem Cell Res Ther; 2009 Dec; 4(4):252-9. PubMed ID: 19500066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons.
    Beggs KJ; Lyubimov A; Borneman JN; Bartholomew A; Moseley A; Dodds R; Archambault MP; Smith AK; McIntosh KR
    Cell Transplant; 2006; 15(8-9):711-21. PubMed ID: 17269442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Six years' experience of tolerance induction in renal transplantation using stem cell therapy.
    Vanikar AV; Trivedi HL; Thakkar UG
    Clin Immunol; 2018 Feb; 187():10-14. PubMed ID: 28757451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mesenchymal stem cells and their immunosuppressive role in transplantation tolerance.
    Contreras-Kallens P; Terraza C; Oyarce K; Gajardo T; Campos-Mora M; Barroilhet MT; Álvarez C; Fuentes R; Figueroa F; Khoury M; Pino-Lagos K
    Ann N Y Acad Sci; 2018 Apr; 1417(1):35-56. PubMed ID: 28700815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy.
    Takeuchi A; Kato K; Akashi K; Eto M
    Int J Urol; 2018 Feb; 25(2):112-120. PubMed ID: 29105189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transforming Growth Factor-β Partially Reversed the Immunosuppressive Effect of Mesenchymal Stem Cells in Mice.
    Zhao J; Qi YJ; Wang X; Jiao Y; Gong HM; Zhang JX; Jiang DY
    Transplant Proc; 2018 Dec; 50(10):3851-3857. PubMed ID: 30577277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stem cell secretome attenuates acute rejection in rat lung allotransplant.
    Pieróg J; Fytianos K; Tamò L; Simillion C; Taddeo A; Kocher G; Gugger M; Grodzki T; Heller M; Blank F; Geiser T; Schmid RA; Gazdhar A
    Interact Cardiovasc Thorac Surg; 2019 May; 28(5):812-818. PubMed ID: 30508108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.